CLINICAL_TRIALS
trial_result
· 2022-04-28
Clinical Trial Update: Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer. [Phase 2]
Summary
Phase 2 neoadjuvant therapy study for clinically staged I-III HER2-positive breast cancer; results completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Brown University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-04-28